Market Analysts see Pfizer Inc. [PFE] gaining to $55. Time to buy?

Pfizer Inc. [NYSE: PFE] plunged by -$0.49 during the normal trading session on Friday and reaching a high of $44.56 during the day while it closed the day at $44.08. The company report on September 22, 2022 that Pfizer Declares Fourth-Quarter 2022 Dividend.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Board of Directors approves quarterly cash dividend of $0.40 per share.

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 fourth-quarter 2022 dividend on the company’s common stock, payable December 5, 2022, to holders of the Common Stock of record at the close of business on November 4, 2022. The fourth-quarter 2022 cash dividend will be the 336th consecutive quarterly dividend paid by Pfizer.

Pfizer Inc. stock has also loss -4.24% of its value over the past 7 days. However, PFE stock has declined by -14.56% in the 3 months of the year. Over the past six months meanwhile, it has lost -16.18% and lost -25.35% year-on date.

The market cap for PFE stock reached $250.14 billion, with 5.61 billion shares outstanding and 5.61 billion shares in the current float. Compared to the average trading volume of 17.83M shares, PFE reached a trading volume of 18826274 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Pfizer Inc. [PFE]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PFE shares is $56.81 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PFE stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

SVB Leerink have made an estimate for Pfizer Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on May 23, 2022. While these analysts kept the previous recommendation, Morgan Stanley raised their target price to Equal-Weight. The new note on the price target was released on April 06, 2022, representing the official price target for Pfizer Inc. stock. Previously, the target price had yet another raise from $59 to $70, while BofA Securities kept a Buy rating on PFE stock. On January 03, 2022, analysts increased their price target for PFE shares from 44 to 65.

The Average True Range (ATR) for Pfizer Inc. is set at 1.00, with the Price to Sales ratio for PFE stock in the period of the last 12 months amounting to 2.47. The Price to Book ratio for the last quarter was 2.83, with the Price to Cash per share for the same quarter was set at 5.87. Price to Free Cash Flow for PFE in the course of the last twelve months was 12.78 with Quick ratio for the last quarter at 1.20.

PFE stock trade performance evaluation

Pfizer Inc. [PFE] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.24. With this latest performance, PFE shares dropped by -7.06% in over the last four-week period, additionally sinking by -16.18% over the last 6 months – not to mention a drop of -0.25% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PFE stock in for the last two-week period is set at 34.01, with the RSI for the last a single of trading hit 31.48, and the three-weeks RSI is set at 36.12 for Pfizer Inc. [PFE]. The present Moving Average for the last 50 days of trading for this stock 48.37, while it was recorded at 44.56 for the last single week of trading, and 51.22 for the last 200 days.

Pfizer Inc. [PFE]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Pfizer Inc. [PFE] shares currently have an operating margin of +25.58 and a Gross Margin at +57.67. Pfizer Inc.’s Net Margin is presently recorded at +27.57.

Return on Equity for this stock inclined to 31.92, with Return on Assets sitting at 13.35.

Pfizer Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.40.

Earnings per share (EPS) analysis for Pfizer Inc. [PFE] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PFE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Pfizer Inc. go to 5.40%.

Pfizer Inc. [PFE]: Insider Ownership positions

There are presently around $171,304 million, or 70.40% of PFE stock, in the hands of institutional investors. The top three institutional holders of PFE stocks are: VANGUARD GROUP INC with ownership of 488,445,127, which is approximately 1.958% of the company’s market cap and around 0.05% of the total institutional ownership; BLACKROCK INC., holding 435,152,528 shares of the stock with an approximate value of $19.18 billion in PFE stocks shares; and STATE STREET CORP, currently with $12.66 billion in PFE stock with ownership of nearly 0.126% of the company’s market capitalization.

Positions in Pfizer Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 1,541 institutional holders increased their position in Pfizer Inc. [NYSE:PFE] by around 215,872,667 shares. Additionally, 1,409 investors decreased positions by around 115,904,062 shares, while 361 investors held positions by with 3,554,425,890 shares. The mentioned changes placed institutional holdings at 3,886,202,619 shares, according to the latest SEC report filing. PFE stock had 130 new institutional investments in for a total of 12,009,600 shares, while 123 institutional investors sold positions of 18,361,344 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here